Dachaigh › Cancer briste triple-negative › Virginia › Arlington
Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Arlington, VA
Tha 20 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air Arlington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
- NEXT Virginia, Fairfax · 11 mìle air falbh
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
A’ fastadhÌre 1/2
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study of AVZO-021 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mìle air falbh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A’ fastadhÌre 3
- Inova Fairfax Hospital, Fairfax · 11 mìle air falbh
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Research Site, Fairfax · 11 mìle air falbh
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
A’ fastadhÌre 1
- Normunity Investigational Site, Fairfax · 11 mìle air falbh
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Clinical Trial Site, Fairfax · 11 mìle air falbh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A’ fastadhÌre 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology Virginia, Fairfax · 11 mìle air falbh
A Study of LY4175408 in Participants With Advanced Cancer
A’ fastadhÌre 1
- NEXT Virginia, Fairfax · 11 mìle air falbh
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mìle air falbh
Study of XB010 in Subjects With Solid Tumors
A’ fastadhÌre 1
- Inova Schar Cancer, Fairfax · 11 mìle air falbh
- NEXT Virginia, Fairfax · 11 mìle air falbh
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A’ fastadhÌre 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mìle air falbh
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
A’ fastadhÌre 1
- Dren Investigational Site, Fairfax · 11 mìle air falbh
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile
- Houston, TX42 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Nashville, TN28 sgrùdaidhean
- Los Angeles, CA27 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- San Antonio, TX23 sgrùdaidhean
- St. Louis, MO21 sgrùdaidhean
- Atlanta, GA20 sgrùdaidhean
- Dallas, TX18 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Columbus, OH16 sgrùdaidhean
- Grand Rapids, MI15 sgrùdaidhean
Sgrùdaidhean eile ann an Arlington
- Aillse Sgamhain Neo-chealla-beag104 sgrùdaidhean
- Ailse metastatach53 sgrùdaidhean
- Aillse colorectal52 sgrùdaidhean
- Aillse (gach seòrsa)48 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Cancer Ovarian46 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Ailse Endometrial39 sgrùdaidhean
- Cancer Pancreatic33 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil26 sgrùdaidhean
- Ailse sgamhain cealla bheag23 sgrùdaidhean
- Aillse a' Bhroinn20 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.